Merck Announces US FDA Acceptance of Biologics Licence Application for KEYTRUDA
By, Admin1 min read
Share
Merck announced the U.S. Food and Drug Administration (FDA) has accepted for review a new supplemental Biologics Licence Application (sBLA) seeking approval for KEYTRUDA, Merck
Found this useful? Share it with your team.
Newsletter
Stay ahead with Clival insights
Subscribe to get the latest updates, data releases and industry information — straight to your inbox.
